Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Heart Failure

  Free Subscription


3 Am Heart J
2 Am J Cardiol
4 Cardiol Clin
4 Circ Heart Fail
1 Circulation
7 Eur J Heart Fail
1 Heart
4 Int J Cardiol
2 J Am Coll Cardiol
2 J Card Fail
7 J Cardiol
1 J Thorac Cardiovasc Surg
1 N Engl J Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. GHAZI L, Desai NR, Simonov M, Yamamoto Y, et al
    Rationale and Design of a Cluster-Randomized Pragmatic Trial Aimed at Improving Use of Guideline Directed Medical Therapy in Outpatients with Heart Failure: PRagmatic Trial Of Messaging to Providers about Treatment of Heart Failure (PROMPT-HF).
    Am Heart J. 2021 Nov 19. pii: S0002-8703(21)00461.
    PubMed         Abstract available

  2. ECHOUFFO-TCHEUGUI JB, Mwasongwe SE, Musani SK, Hall ME, et al
    Dysglycemia and Incident Heart Failure among Blacks: The Jackson Heart Study.
    Am Heart J. 2021 Nov 19. pii: S0002-8703(21)00446.
    PubMed         Abstract available

  3. BREATHETT KK, Xu H, Sweitzer NK, Calhoun E, et al
    Is the Affordable Care Act Medicaid Expansion Associated with Receipt of Heart Failure Guideline-Directed Medical Therapy By Race and Ethnicity?
    Am Heart J. 2021 Nov 20. pii: S0002-8703(21)00462.
    PubMed         Abstract available

    Am J Cardiol

  4. AL-ABDOUH A, Mhanna M, Barbarawi M, Abusnina W, et al
    A Meta-Analysis of the Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure and Preserved Ejection Fraction.
    Am J Cardiol. 2021 Nov 16. pii: S0002-9149(21)01036.

  5. COSTA R, Trepa M, Oliveira M, Frias A, et al
    Heart Failure Incidence Following ST-Elevation Myocardial Infarction.
    Am J Cardiol. 2021 Nov 21. pii: S0002-9149(21)01050.
    PubMed         Abstract available

    Cardiol Clin

  6. ALAMRI AK, Ma CL, Ryan JJ
    Left Heart Disease-Related Pulmonary Hypertension.
    Cardiol Clin. 2022;40:69-76.
    PubMed         Abstract available

  7. SHERMAN AE, Saggar R, Channick RN
    Update on Medical Management of Pulmonary Arterial Hypertension.
    Cardiol Clin. 2022;40:13-27.
    PubMed         Abstract available

    The Pathobiology of Pulmonary Arterial Hypertension.
    Cardiol Clin. 2022;40:1-12.
    PubMed         Abstract available

  9. AHMAD K, Khangoora V, Nathan SD
    Lung Disease-Related Pulmonary Hypertension.
    Cardiol Clin. 2022;40:77-88.
    PubMed         Abstract available

    Circ Heart Fail

  10. UPADHYA B, Willard JJ, Lovato LC, Rocco MV, et al
    Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT.
    Circ Heart Fail. 2021 Nov 26:CIRCHEARTFAILURE121008322.
    PubMed         Abstract available

  11. BUTT JH, Adamson C, Docherty KF, de Boer RA, et al
    Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
    Circ Heart Fail. 2021 Nov 22:CIRCHEARTFAILURE121008837.
    PubMed         Abstract available

  12. DESAI AS, Vaduganathan M, Cleland JG, Claggett BL, et al
    Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial.
    Circ Heart Fail. 2021 Nov 22:CIRCHEARTFAILURE121008597.
    PubMed         Abstract available

  13. RETHY L, Cohen JB
    Intensive Blood Pressure Lowering for Prevention of Heart Failure With Preserved and Reduced Ejection Fractions.
    Circ Heart Fail. 2021 Nov 26:CIRCHEARTFAILURE121009277.


  14. BARALLOBRE-BARREIRO J, Radovits T, Fava M, Mayr U, et al
    The Extracellular Matrix in Heart Failure: The Role of Adamts5 In Proteoglycan Remodelling.
    Circulation. 2021 Nov 22. doi: 10.1161/CIRCULATIONAHA.121.055732.
    PubMed         Abstract available

    Eur J Heart Fail

  15. FAUCHIER L, Bisson A, Lip GYH
    Age, sex and clinical outcomes with digoxin vs beta-blocker in permanent atrial fibrillation with heart failure.
    Eur J Heart Fail. 2021 Nov 23. doi: 10.1002/ejhf.2389.

  16. ALNUWAYSIR RIS, Grote Beverborg N, Hoes MF, Markousis-Mavrogenis G, et al
    Additional Burden of Iron Deficiency in Heart Failure Patients beyond the Cardio-Renal-Anaemia Syndrome: Findings from the BIOSTAT-CHF Study.
    Eur J Heart Fail. 2021 Nov 23. doi: 10.1002/ejhf.2393.
    PubMed         Abstract available

  17. CULIC V
    Digoxin and beta-blockers in patients with heart failure.
    Eur J Heart Fail. 2021 Nov 23. doi: 10.1002/ejhf.2392.

  18. NAITO R, Kasai T
    Bereavement of a child as a risk of heart failure.
    Eur J Heart Fail. 2021 Nov 23. doi: 10.1002/ejhf.2388.

  19. BUTLER J, Anker SD, Siddiqi TJ, Coats AJS, et al
    Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.
    Eur J Heart Fail. 2021 Nov 20. doi: 10.1002/ejhf.2386.
    PubMed         Abstract available

  20. Corrigendum to 'High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality' [Eur J Heart Fail 2021;23:919-932].
    Eur J Heart Fail. 2021 Nov 24. doi: 10.1002/ejhf.2383.

  21. FERREIRA JP, Liu J, Claggett BL, Vardeny O, et al
    Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCAT.
    Eur J Heart Fail. 2021 Nov 9. doi: 10.1002/ejhf.2376.
    PubMed         Abstract available


  22. NEDKOFF L, Weber C
    Heart failure: not just a disease of the elderly.
    Heart. 2021 Nov 22. pii: heartjnl-2021-320273. doi: 10.1136/heartjnl-2021-320273

    Int J Cardiol

  23. OSUNDOLIRE S, Naqvi S, Nunes AP, Lapane KL, et al
    Heart failure among US nursing home residents with diabetes mellitus.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01777.
    PubMed         Abstract available

  24. KITAI T
    Early intravenous vasodilator therapy in acute decompensated heart failure: Is the time-to-treat concept still applicable in a pre-hospital setting?
    Int J Cardiol. 2021 Nov 20. pii: S0167-5273(21)01859.

  25. REA F, Iorio A, Barbati G, Bessi R, et al
    Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01788.

  26. FUDIM M, Devaraj S, Chukwurah M, Ajam T, et al
    Prognosis for patients with heart failure and reduced ejection fraction with and without diabetes: A 7 year nationwide veteran administration analysis.
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01849.
    PubMed         Abstract available

    J Am Coll Cardiol

  27. HINKEL R, Batkai S, Bahr A, Bozoglu T, et al
    AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
    J Am Coll Cardiol. 2021;77:2923-2935.
    PubMed         Abstract available

  28. GANDHI PU, Windish DM
    Heart Failure Biomarker Education: An Unmet Need in Cardiovascular Fellowship Training.
    J Am Coll Cardiol. 2021;78:2265-2266.

    J Card Fail

  29. JENKINS H, Rupert DJ, Etta V, Peinado S, et al
    Examining Information Needs of Heart Failure Patients and Family Companions using a Pre-Visit Question Prompt List and Audiotaped Data: Findings from a Pilot Study.
    J Card Fail. 2021 Nov 21. pii: S1071-9164(21)00474.
    PubMed         Abstract available

  30. JABER D, Vargas F, Nguyen L, Ringel J, et al
    Prescriptions for Potentially Inappropriate Medications from the Beers Criteria Among Older Adults Hospitalized for Heart Failure.
    J Card Fail. 2021 Nov 21. pii: S1071-9164(21)00479.
    PubMed         Abstract available

    J Cardiol

  31. YOKOYAMA H, Shishido K, Tobita K, Moriyama N, et al
    Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy.
    J Cardiol. 2021;77:254-262.
    PubMed         Abstract available

  32. YAMASHITA M, Kamiya K, Hamazaki N, Nozaki K, et al
    Work status before admission relates to prognosis in older patients with heart failure partly through social frailty.
    J Cardiol. 2021 Nov 21. pii: S0914-5087(21)00307.
    PubMed         Abstract available

  33. NAKAO Y, Kawakami H, Saito M, Inoue K, et al
    Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan.
    J Cardiol. 2021 Nov 16. pii: S0914-5087(21)00287.
    PubMed         Abstract available

  34. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed         Abstract available

  35. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed         Abstract available

  36. NAKAJIMA DOI S, Seguchi O, Yamamoto M, Fujita T, et al
    Impact of bridge-to-bridge strategies from paracorporeal to implantable left ventricular assist devices on the pre-heart transplant outcome: A single-center analysis of 134 cases.
    J Cardiol. 2021;77:408-416.
    PubMed         Abstract available

  37. DAYANAND S, Martinez JM, Figueredo VM, Gupta S, et al
    Mechanical Circulatory Support in Women.
    J Cardiol. 2021;77:209-216.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

    Commentary: Preventive treatment of right-sided heart failure before adulthood?
    J Thorac Cardiovasc Surg. 2021 Nov 4. pii: S0022-5223(21)01533.

    N Engl J Med

  39. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:1845-1855.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.